Arrhythmia risk: Electrophysiological studies and monophasic action potentials

PACE - Pacing and Clinical Electrophysiology

Volumn 20, Issue 10 II, 1997, Pages 2560-2565

  Wellens, Hein J J ^a   Doevendans, Peter ^a   Smeets, Joep ^a   Rodriguez, Luz Maria ^a   Dulk, Karel Den Dulk ^a   Timmermans, Carl ^a   Vos, Marc ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac arrhythmias; Electrophysiological studies; Monophasic action potentials; Programmed electrical stimulation of the heart; Risk stratification

Indexed keywords

ACTION POTENTIAL; CONFERENCE PAPER; ELECTROPHYSIOLOGY; ELECTROSTIMULATION; HEART ARRHYTHMIA; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; RISK ASSESSMENT; TORSADE DES POINTES;

ACTION POTENTIALS; ARRHYTHMIA; CARDIAC PACING, ARTIFICIAL; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; RISK ASSESSMENT; RISK FACTORS; VENTRICULAR FUNCTION, LEFT;

EID: 0030689037     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1997.tb06105.x     Document Type: Article

References (42)

1. Durrer D, Schoo L, Schuilenburg RM, et al. The role of premature beats in the initiation and termination of supraventricular tachycardia in the Wolff-Parkinson-White syndrome. Circulation 1967; 36:644.
2. Coumel PH, Cabrol C, Fabiatio A, et al. Tachycardia permanente par rhythme réciproque. Arch Mal Coeur 1967; 60:1830.
3. Wellens HJJ, Schuilenburg RM, Durrer D. Electrical stimulation of the heart in patients with ventricular tachycardia. Circulation 1972; 46:216.
4. Wellens HJJ, Durrer D. Relation between refractory period of the accessory pathway and ventricular frequency during atrial fibrillation in patients with Wolff-Parkinson-White syndrome. Am J Cardiol 1974; 33:178.
5. Wellens HJJ. Value and limitations of programmed electrical stimulation of the heart in the study and treatment of tachycardias. George C. Griffith Lecture. Circulation 1978; 57(5):845.
6. Richards D, Cody D, Denniss A, et al. Ventricular electrical instability: A predictor of death after myocardial infarction. Am J Cardiol 1983; 51:75-80.
7. Marchlinski F, Buxton A, Waxman H, et al. Identifying patients at risk of sudden death after myocardial infarction. Am J Cardiol 1983; 52:1190-1196.
8. Zehender M, Brugada P, Geibel A, et al. Programmed electrical stimulation in healed myocardial infarction using a standardized ventricular stimulation protocol. Am J Cardiol 1987; 59:578-585.
9. Roy D, Marchand E, Theroux P, et al. Programmed ventricular stimulation in survivors of an acute myocardial infarction. Circulation 1985; 72:487-194.
10. Bhandari A, Hong R, Kotlewski A, et al. Frequency and significance of induced sustained ventricular tachycardia or fibrillation 2 weeks after acute myocardial infarction. Am J Cardiol 1985; 5:737-742.
11. Richards D, Byth K, Ross D, et al. What is the best predictor of spontaneous ventricular tachycardia and sudden death after myocardial infarction? Circulation 1991; 83:756-763.
12. Kersschot I, Brugada P, Ramentol M, et al. Effects of early reperfusion in acute myocardial infarction on arrhythmias induced by programmed stimulation: A prospective randomized study. J Am Coll Cardiol 1986; 7:1234-1242.
13. Doevendans PA, Cheriex EC, Van der Zee R, et al. Risk stratification in the thrombolytic era: Results of a prospective study. Cardiologie 1996; 3:319-323.
14. Wellens H, Bär F, Lie K, et al. Effect of procainamide, propranolol and verapamil on mechanism of tachycardia in patients with chronic recurrent ventricular tachycardia. Am J Cardiol 1977; 40:579-585.
15. Mason J, Winkle R. Electrode-catheter arrhythmia induction in the selection and assessment of antiarrhythmic drug therapy for recurrent ventricular tachycardia. Circulation 1978; 58:971-985.
16. Horowitz L, Josephson M, Farshidi A, et al. Recurrent sustained ventricular tachycardia. 3. Role of electrophysiologic study in selection of antiarrhythmic regimens. Circulation 1978; 58:986-997.
17. Wilber D, Garan H, Finkelstein D, et al. Out-of-hospital cardiac arrest: Use of electrophysiologic testing in the prediction of long-term outcome. N Engl J Med 1988; 318:19-24.
18. Swerdlow C, Winkle R, Mason J. Determinants of survival in patients with ventricular tachyarrhythmias. N Engl J Med 1983; 308:1436-1442.
19. Steinbeck G, Andresen D, Bach P, et al. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med 1992; 327:987-992.
20. Poole J, Mathisen T, Kudenchuk P, et al. Long-term outcome in patients who survive out-of-hospital ventricular fibrillation and undergo electrophysiologic studies: Evaluation by electrophysiologic subgroups. J Am Coll Cardiol 1990; 16:657-665.
21. CASCADE Investigators. Randomized Antiarrhythmic Drug Therapy in Survivors of Cardiac Arrest (the CASCADE study). Am J Cardiol 1993; 72:280-287.
22. ESVEM Investigators. Determinants of predicted antiarrhythmic drug efficacy in the ESVEM trial. Circulation 1993; 79:1354-1360.
23. Mason JW. A randomized comparison of seven antiarrhythmic drugs in patients with ventriculartachyarrhythmias. N Engl J Med 1993; 329:445-451.
24. Rodriguez LM, Sternick EB, Smeets JLRM, et al. Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after myocardial infarction. Heart 1996; 75:23-28.
25. Moss AJ. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmias. N Engl J Med 1996; 335:1933-1940.
26. Anderson KP, Mason JW. Clinical value of cardiac electrophysiological studies. In Zipes D, Jalife J (eds.): Cardiac Electrophysiology. From Cell to Bedside. Philadelphia, W.B. Saunders, 1995, pp. 1133-1150.
27. Meinertz T, Treese N, Kasper W, et al. Determinants of prognosis in idiopathic dilated cardiomyopathy as determined by programmed electrical stimulation. Am J Cardiol 1985; 56:337-341.
28. Das S, Morady F, DiCardilo L, et al. Prognostic usefulness of programmed ventricular stimulation in idiopathic dilated cardiomyopathy without symptomatic ventricular arrhythmias. Am J Cardiol 1986; 58:998-1000.
29. Poll D, Marchlinski F, Buxton A, et al. Usefulness of programmed stimulation in idiopathic dilated cardiomyopathy. Am J Cardiol 1986; 58:992-997.
30. Gössinger H, Jung M, Wagner L, et al. Prognostic role of inducible ventricular tachycardia in patients with dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia. Int J Cardiol 1990; 29:215-220.
31. Brembilla-Perrot B, Donetti J, Terrier de la Chaise A, et al. Diagnostic value of ventricular stimulation in patients with idiopathic dilated cardiomyopathy. Am Heart J 1991; 121:1124-1131.
32. Fananapazir L, Tracy C, Leon M, et al. Electrophysiologic abnormalities in patients with hypertrophic cardiomyopathy. Circulation 1989; 80:1259-1268.
33. Fananapazir L, Chang A, Epstein S, et al. Prognostic determinants in hypertrophic cardiomyopathy: Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation 1992; 86:730-740.
34. Geibel A, Brugada P, Zehender M, et al. Value of programmed electrical stimulation using a standardized ventricular stimulation protocol in hypertrophic cardiomyopathy. Am J Cardiol 1987; 60:738-739.
35. Kuck K, Kunze K, Schluter M, et al. Programmed electrical stimulation in hypertrophic cardiomyopathy: Results in patients with and without cardiac arrest of syncope. Eur Heart J 1988; 9:177-188.
36. Franz MR. Method and theory of monophasic action potential recording. Prog Cardiovasc Dis 1991; 33:347-368.
37. Zipes DP. Monophasic action potentials in the diagnosis of triggered arrhythmias. Prog Cardiovasc Dis 1991; 33:385-396.
38. Yuan S, Blomström-Lundqvist C, Olsson SB. Monophasic action potentials: Concepts to practical applications. J Cardiovasc Electrophysiol 1994; 5:287-308.
39. Habbab MA, El-Sherif N. Drug-induced torsades de pointes: Role of early afterdepolarizations and dispersion of repolarization. Am J Med 1990; 89:241-246.
40. Linker NJ, Camm AJ, Ward DE. Dynamics of ventricular repolarization in the congenital long QT syndromes. Br Heart J 1991; 66:230-237.
41. Shimizu W, Ohe T, Kurita T, et al. Early afterdepolarizations induced by isoproterenol in patients with congenital long QT-syndrome. Circulation 1991; 84:1915-1923.
42. De Vreede-Swagemakers J, Gorgels A, Dubois-Arbomv W, et al. Out-of-hospital cardiac arrest in the 1990's. A population based study in the Maastricht on incidence, characteristics and survival. JACC (in press).